samedan logo
 
 
 
spacer
home > ebr > autumn 2020 > how pharma can conquer the next pandemic
PUBLICATIONS
European Biopharmaceutical Review

How Pharma Can Conquer the Next Pandemic

The COVID-19 pandemic has brought a level of global disruption unseen in most of our lifetimes, with countries around the world continuing to grapple with infection rates and lockdown restrictions.

While we’re still some way away from a realistic end to the crisis, we are starting to see some positive developments rising from the gloom: countries in Europe and Asia are seeing their mitigation and suppression efforts starting to bear fruit, and track and trace systems have been implemented and are improving in efficacy by the day. Treatments, and our general understanding of the virus, are also progressing, with dexamethasone emerging as a viable treatment for the sickest patients. Meanwhile, early clinical trials of several different vaccines have had promising results.

Unsurprisingly, the pharmaceutical industry has led the charge in the battle against COVID-19 in many respects, and will continue to be at the forefront of the global response in the months to come. Given the upheaval that the current outbreak has caused, the way the world responds will act as a blueprint for future pandemics. With this in mind, the pharma industry must learn as many valuable lessons from the situation as possible.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

 You must be a member of the site to make a comment.
spacer
Vladimir Tkachenko, a pharmaceutical sciences expert, is General Manager of Amaxa Pharma, a UK-headquartered pharma company focused on life-threatening therapeutic areas such as oncology and neonatology in the Commonwealth of Independent States countries. Within this role, Vladimir is responsible for the general management and success of the company, developing sales strategy, implementing managerial accounting strategy, preparing operation budgets and licensing. Since joining Amaxa Pharma in 2012, Vladimir has been instrumental in its success in Europe, driving effective partnerships and bringing life-changing prescription and non-prescription medicines for the treatment of patients suffering from cancer, blood-related diseases, premature birth, and other life-threatening illnesses.
spacer
Vladimir Tkachenko
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Complete Family of Next Generation Centrifuges Deliver Optimal Sample Safety, Functionality and Ergonomics

Thermo Fisher Scientific, the world leader in serving science, has further expanded its Thermo Scientific General Purpose Pro Centrifuge Series with the addition of two new models designed to meet the needs of biopharmaceutical, cell and gene therapy, and academic research laboratories, as well as clinical diagnostic facilities, for enhanced sample safety and reproducibility, improved ergonomics and reduced noise levels.
More info >>

White Papers

Another Successful Visit Against the Odds

Medical Research Network (MRN) Limited

Our dedicated team of nurses, couriers and project managers deliver, come rain or shine. Making sure a Clinical Trial visit can go ahead in the home can be a complex process, and last month bad weather nearly stopped play on an important Home Trial Support visit. Thanks to the commitment and dedication from the entire team it went ahead against the odds.
More info >>

 
Industry Events

Pharma Integrates 2021

16 November 2021, VIRTUAL CONFERENCE

Now in its tenth year, Pharma Integrates is a unique event bringing together pharma and healthcare leaders across the Pharmaceutical pipeline to address their needs, to share insights and create debate on crucial topics that influence the future of patient outcomes.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement